Literature DB >> 20516515

A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix.

Claudia A Martinez1, Robert Rosen, Howard Cohen, Carlos E Ruiz.   

Abstract

A patient with a symptomatic mitral paravalvular leak was successfully treated by implantation of an Amplatzer (16 mm) occluder device (AGA Medical, Plymouth, Minnesota) at the defect via percutaneous direct transapical puncture of the left ventricle. We describe a novel technique for closure and immediate hemostasis of the transapical access tract, comprising two stainless steel coils deployed across the myocardial wound and a hemostatic matrix injected at the epicardium and within the subcutaneous tract.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20516515

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN： 1042-3931            Impact factor:   2.022


  3 in total

1.  Transapical septal occluder for paravalvular leakage of the mitral valve: a novel method for interventional treatment in high-risk patients.

Authors:  Karim Ibrahim; Marian Christoph; Joachim Nicolai; Hagen Schroetter; Thorsten Schmidt; Utz Kappert; Steffen Schoen; Ruth H Strasser
Journal:  Clin Res Cardiol       Date:  2011-06-05       Impact factor: 5.460

Review 2.  Percutaneous mitral and aortic paravalvular leak repair: indications, current application, and future directions.

Authors:  Ronald K Binder; John G Webb
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

3.  Direct percutaneous left ventricular access and port closure: pre-clinical feasibility.

Authors:  Israel M Barbash; Christina E Saikus; Anthony Z Faranesh; Kanishka Ratnayaka; Ozgur Kocaturk; Marcus Y Chen; Jamie A Bell; Renu Virmani; William H Schenke; Michael S Hansen; Michael C Slack; Robert J Lederman
Journal:  JACC Cardiovasc Interv       Date:  2011-12       Impact factor: 11.195
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.